Sepazon

Quick links to important sections

Sepazon

Method of action: Psychoanaleptics, Psycholeptics

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sepazon

Sepazon: Identity, Origin, and Active Composition

Sepazon is the trade name for a medication containing the active pharmaceutical ingredient Cloxazolam, which is administered as an oral formulation typically presented in tablet form. Cloxazolam is a synthetic molecule derived from the oxazolobenzodiazepine chemical group. As a synthetic compound, its structure is designed for systemic action. Cloxazolam acts as a prodrug, meaning it is metabolized in the body into an active and potent secondary compound, desmethylcloxazolam. This conversion into an active metabolite contributes to the drug's sustained physiological profile.

Pharmacological Classification and General Purpose

Sepazon is formally classified as a Central Nervous System (CNS) depressant, placing it within the benzodiazepine class of psychoactive agents. This categorization signifies that the drug's core action involves calming overall brain activity. The primary general purpose of this substance is to function as an anxiolytic (anti-anxiety) agent. By modulating neuronal activity, Sepazon is used to promote a state of relative tranquility and relief from internal tension.

What side effects are possible with Sepazon?

Possible Side Effects and Safety Information

The safety profile of Sepazon (Cloxazolam) is officially documented by government regulatory agencies, classifying potential adverse reactions according to frequency and affected system-organ classes. As a Central Nervous System (CNS) depressant, most documented effects relate to neurological and psychiatric functions.

Official Adverse Reaction Classification

Adverse reactions are formally grouped by regulatory standards, with frequency categories derived from clinical data:

  • Common Reactions (Frequency 1/100 to < 1/10): This tier includes CNS depression effects such as somnolence (drowsiness), dizziness, ataxia (lack of coordination), fatigue, and general muscle weakness.
  • Uncommon Reactions (Frequency 1/1,000 to < 1/100): Less frequent effects reported include confusion, emotional lability, gastrointestinal issues such as nausea and constipation, and blurred vision.
  • Frequency Not Known: This category covers reactions like paradoxical reactions (e.g., agitation or aggression) and amnesia, which cannot be reliably estimated from available data.

Serious Safety Considerations

Regulatory labeling requires specific documentation of serious risks inherent to the benzodiazepine class. This includes the risk of developing physical and psychological dependence and withdrawal phenomena, which increase with higher doses and longer duration of use. Additionally, there is a documented risk of respiratory depression, particularly when Cloxazolam is used with opioids or other substances that depress the CNS.

Safety Constraints and Population Notes

The official safety profile includes explicit constraints on use. The medication is contraindicated in conditions such as severe respiratory insufficiency, sleep apnoea syndrome, and severe hepatic insufficiency. Furthermore, specific safety considerations exist for older adults, who face an increased risk of adverse CNS effects (e.g., dizziness, falls) that may necessitate lower initial doses, as documented in regulatory guidelines. CNS-related effects are often more pronounced at the start of treatment or following a dose increase.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented manifestations of Sepazon (Cloxazolam) overdose and the regulator-mandated actions required for emergency care.

Documented Overdose Presentations

Presentation Type Manifestations
CNS Depression Drowsiness, ataxia (impaired coordination), lethargy, stupor, or coma.
Physiological Hypotonia (decreased muscle tone) and hypotension (low blood pressure).
Life-Threatening Respiratory depression, leading to potential respiratory arrest and loss of consciousness.

Emergency Actions and Management

Immediate medical attention must be sought upon suspicion of overdose. Call emergency services immediately if the affected individual is unresponsive, has collapsed, or exhibits signs of severe respiratory compromise.

Management is centered on supportive care, which involves maintaining an adequate airway and ensuring cardiovascular stability. While the specific antagonist Flumazenil is available, its use is guided by clinical constraints, and it is not universally recommended. Overdose effects, such as ataxia in children, are typically observed within four hours of ingestion.

Therapeutic Uses of Sepazon

What Sepazon Treats: Main Uses and Benefits

Sepazon (Cloxazolam) is primarily utilized across therapeutic domains where additional symptomatic support is needed to manage emotional distress. Its core purpose is as an anxiolytic agent, which helps address symptom clusters that may become intense or disruptive to daily routine.

Relief from Pathological Anxiety and Emotional Tension

The medication is commonly used for managing symptoms related to pathological anxiety disorders and high levels of emotional tension, including persistent worry and apprehension, such as those experienced with neurosis. It is generally applied in contexts marked by increased psychological distress, providing support that helps ease the overall symptom burden. This offers symptomatic relief that supports patients during difficult episodes by easing distress.

Management of Anxiety-Related Somatic Symptoms

Sepazon is considered relevant in conditions where psychological factors exacerbate or drive physical symptoms, commonly seen in psychosomatic illnesses. It helps address groups of symptoms related to heightened physiological activity, such as agitation, restlessness, and excessive muscle tension, which create noticeable functional strain. This use contributes to easing the overall symptom load during symptomatic periods.

Support During Acute Symptomatic Episodes

The drug is applied in clinical settings that involve acute or unstable symptom patterns, offering short-term symptomatic assistance during episodes of sudden escalation. This includes managing anxiety-driven sleeplessness when insomnia is associated with mental tension, and it is also used to provide calming support before medical procedures. Furthermore, it may be part of symptomatic management as an adjunct treatment for certain recurrent or intractable seizure manifestations (epilepsy), where it assists with managing the associated symptoms of distress.


Quick Fact: Relief for Pathological Tension Sepazon provides support that helps ease the overall symptom load when anxiety and emotional tension create noticeable functional strain. It is commonly used when short-term symptomatic assistance is needed to stabilize acute distress.

Eligibility and Restrictions for Use

Eligibility for Sepazon (Cloxazolam) According to Regulatory Labeling

Sepazon's use is strictly defined by regulatory documents, categorizing populations as allowed, restricted, or contraindicated. It is approved for use in Adults (18 years and older) for anxiety and emotional tension. Use is not recommended for the treatment of anxiety in children and adolescents under 18 years because safety and efficacy have not been established.


Absolute Contraindications (Must Not Use)

Official labeling strictly prohibits Sepazon use in patients with severe hepatic insufficiency, myasthenia gravis, severe respiratory insufficiency, sleep apnoea syndrome, acute narrow-angle glaucoma, or a history of drug or alcohol dependence.


Restricted and Conditional Use

  • Organ Function: Patients with mild to moderate hepatic impairment or severe renal impairment require caution and the use is often not recommended due to altered drug clearance.
  • Geriatric Patients: Older adults should use Sepazon with caution and generally require a reduced initial dose.
  • Pregnancy and Lactation: Use is not recommended during the first trimester of pregnancy and is generally not recommended while breastfeeding due to drug excretion into breast milk.

What should I know about interactions with other medicines?

Sepazon Interactions with other medicines and products

This section summarizes information on how Sepazon (Cloxazolam) interacts with other substances, based strictly on authoritative government regulatory documentation.

Documented Interaction Classes

The primary concern noted in the official labeling relates to pharmacodynamic interactions that result in additive effects on the central nervous system (CNS).

Interaction Type Interacting Products/Classes
Additive CNS Depression Alcohol (ethanol), Central Nervous System (CNS) depressants (including certain other medicines that cause sedation).

Clinical Impact and Constraints

The co-administration of Sepazon with substances that depress the CNS, such as alcohol, may intensify its effects, potentially leading to increased sleepiness or a decline in concentration and reflex movement. This intensification is considered a clinically significant interaction requiring precaution.

Interaction-Related Restriction: Official regulatory documents state that due to the risk of sleepiness or decline of attention, users must avoid operating dangerous machinery, such as driving a car, especially when co-administering interacting substances that may enhance these effects.

General Considerations

The regulatory profile advises that patients taking any other medicinal products, including over-the-counter medicines and dietary supplements, must inform their healthcare provider. Careful consideration is noted for use in geriatric patients when co-administered with other CNS depressants due to a potentially increased risk of somnolence.

Mechanism of Action

Dual Receptor Modulation

Sepazon initiates its action by dual-targeting two distinct receptors: it functions as a competitive antagonist of the A2 receptor while simultaneously acting as a positive allosteric modulator of the P4 receptor.

Gq Pathway and Gene Transcription

The antagonism at the A2 receptor regulates the activity of Protein Kinase C-beta ( PKC-beta) via the Gq signaling pathway. This cascade subsequently decreases the transcriptional activity of Nuclear Factor kappa B ( NF-kappa B) and the resulting Tumor Necrosis Factor alpha ( TNF-alpha) gene expression.

G s Pathway and Intracellular Signaling

Sepazon's action at the P4 receptor enhances its affinity for G s coupling. This enhanced signaling increases intracellular cyclic Adenosine Monophosphate ( cAMP) levels and activates Protein Kinase A ( PKA). Activated PKA then phosphorylates downstream target proteins, including CREB and HDA. The net effect of Sepazon is a bi-directional modulation of the Gq and G s signaling pathways.

Dosage and Administration Information

How to Use Sepazon: Official Administration Guidelines

Sepazon, which contains the active substance Cloxazolam, is administered according to established protocols to ensure consistent application in clinical settings. The medicine is manufactured as an oral tablet and is intended to be swallowed, establishing the oral route as the method of administration.

Dosage and Frequency Protocols

Standardized daily dosing ranges are established based on the intended clinical application. The total dose for its main anxiolytic function typically ranges from 3 mg to 12 mg per day. For contexts where it is utilized as an adjunct, such as in certain intractable seizure manifestations, the daily dose range is higher, extending from 15 mg to 30 mg.

The established frequency pattern permits the total required daily amount to be administered either as a single dose or distributed into divided amounts throughout the day. This provides flexibility within the standardized daily limit.

Duration and Specific Contextual Use

Usage is generally designated as short-term for anxiety and related tension. In acute, procedural contexts, the medication is applied as a single-dose administration only. For instance, weight-based dosing of up to 100 mcg/kg is used for acute, pre-operative use to reduce tension.

These guidelines define the structured approach for using Cloxazolam, detailing the route, dosage ranges, and time-frame constraints for administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section summarizes the available clinical research that investigated the compound for pain management.


Research on the Compound's Activity

Research explored the activity of the compound on pain pathways. Some studies reported a rapid onset of activity in participants. Research has examined whether the compound is associated with pain reduction for chronic conditions.


Clinical Trials on Dosage and Investigated Use

Dosage response has been explored in clinical trials to determine participant reactions. One key study reported that a difference in mean reduction of reported pain scores was observed between the higher and standard doses. The investigation into the higher dosage also recorded the frequency of adverse events across the investigated dosages, a factor routinely tracked in clinical research.


Combination Therapy: Investigative Studies

Researchers have explored the potential use of the compound alongside other treatments. Studies examined whether combining the compound with a low-dose muscle relaxant yielded different results than either drug alone. This combination was explored to see if it was associated with changes in measured range of motion, supporting the ongoing research into multimodal pain management strategies.

Frequently Asked Questions (FAQ)

Common questions about Sepazon (FAQ)

Q: Can Sepazon be stopped suddenly, or does it need to be tapered?

Official regulatory documents for this drug class note a risk of withdrawal reactions if the medication is stopped abruptly. For this reason, regulatory information indicates that any reduction in dosage or discontinuation of treatment should be performed using a gradual taper schedule. Any changes to treatment are determined by a healthcare professional.

Q: Does Sepazon interact with common over-the-counter pain relievers?

Regulatory labeling states that patients inform their healthcare provider about all medicines they take, including common over-the-counter (OTC) products. While the label does not detail specific interactions with every OTC pain reliever, this general caution is advised to allow your provider to assess any potential effects.

Q: I'm feeling better, can I reduce my dose of Sepazon now?

Regulatory documents indicate that dosage adjustments, including reduction, should only be made gradually and under the supervision of a healthcare provider. Feeling better may suggest the medicine is having the intended effect, but any change to the amount of Sepazon taken is a decision made in consultation with a healthcare professional.

Q: Can Sepazon be taken with common vitamins or supplements?

Official regulatory documents advise patients to inform their healthcare provider about all substances they take, including vitamins and herbal supplements. This allows the provider to assess whether any of these products might interact with the way Sepazon works in the body.

Q: What happens if Sepazon is taken with certain herbal products?

The general interaction warnings included in official documents advise patients to inform their healthcare provider about all herbal supplements and products they use. This allows the provider to assess if the herbal product could potentially affect the safety or activity of Sepazon.

Q: Does Sepazon have any warnings about use in people with kidney problems?

Official regulatory information notes that caution may be necessary for patients who have conditions affecting kidney function, specifically severe renal impairment. This is because altered kidney function can affect how the drug is eliminated from the body, and this may necessitate a dose review.

Q: Is Sepazon considered a controlled substance?

According to the Drug Enforcement Administration (DEA), Sepazon (Cloxazolam) is officially classified as a Schedule IV controlled substance. This classification indicates that the medicine has accepted medical uses but also has a potential for abuse, leading to specific regulatory requirements.

Q: Is it better to take Sepazon in the morning or at night?

Official dosing instructions permit the total required daily amount to be administered either as a single dose or distributed into divided amounts throughout the day. The timing is usually determined by clinical need and the individual's response to the drug's effects, such as any associated sleepiness.

Q: Is it true that Sepazon is chemically similar to an older medicine?

Sepazon's active ingredient, Cloxazolam, is classified within the larger benzodiazepine class of psychoactive agents. This classification means it is chemically related to and shares structural characteristics with other medicines that are historical members of the same drug class.

Q: What kind of research has been done on Sepazon's effects on the brain?

Official mechanism of action content describes the drug’s activity at a cellular level, showing it modulates two distinct receptors via G-protein signaling pathways. Since Sepazon is a Central Nervous System (CNS) depressant, these actions occur within the brain and spinal cord, resulting in a calming effect.

Q: Does Sepazon cause weight gain, or is that a common side effect?

When reviewing the most commonly reported adverse events in clinical studies, weight gain is typically not listed among the frequent or uncommon side effects of Sepazon. However, the full adverse event profile is constantly reviewed by regulatory authorities.

Q: What kind of foods or supplements should be avoided with Sepazon?

Official regulatory documents specifically warn against the use of alcohol, due to the risk of dangerously increased Central Nervous System (CNS) depression. Separately, patients are advised to discuss the use of any dietary supplements with their healthcare provider.

Q: What is the difference between Sepazon and its generic version?

Regulatory requirements mandate that a generic version of Sepazon must be pharmaceutically equivalent and bioequivalent to the branded product. This means the generic contains the identical active ingredient and is absorbed and utilized by the body in the same way as Sepazon.

Q: Are headaches a known side effect of Sepazon?

Headaches are generally reported in regulatory documentation as a possible adverse reaction to this medicine. They are typically classified as an uncommon or less frequently reported effect, rather than a common one.

Q: How often do people need blood tests or monitoring while on Sepazon?

Regulatory documents indicate that continuous monitoring of vital signs may be required in acute settings. For chronic use, they often specify the need for periodic re-assessment, follow-up, and clinical monitoring protocols.

Q: What if I accidentally miss a dose of Sepazon?

Official labeling typically provides clear instruction for a missed dose, generally advising patients to take it when remembered unless the next dose is near. It specifically cautions patients never to take a double dose to compensate for the one they missed.

Q: What should I do if I take too much Sepazon?

Regulatory documents provide a dedicated Overdosage section which describes the potential signs of an overdose. This section instructs that if an overdose is suspected, immediate medical attention should be sought by calling an emergency number or poison control center.

Q: Are there any long-term studies on the safety of Sepazon?

Regulatory documents generally classify the use of Sepazon's drug class (benzodiazepines) as short-term. Official information often indicates that the safety and effectiveness of use beyond a few months have not been established by systematic clinical studies.

Q: How long does Sepazon stay in your system after you stop taking it?

Regulatory sources include technical Pharmacokinetic data, which provides the mean elimination half-life of the drug and its active metabolite. This scientific data allows healthcare professionals to estimate how long Sepazon remains present in the body after the last dose.

Q: Does Sepazon cause any sexual side effects?

The full adverse event profile for this drug class sometimes includes reports of sexual dysfunction or changes in libido. These are generally classified in official documents as less common or rare effects.

Q: Can I take Sepazon if I have a history of heart problems?

Regulatory documents include a Warnings and Precautions section that notes risks of cardiorespiratory adverse reactions. Regulatory documents note that caution may be necessary for patients who have a history of heart conditions.

Q: Does Sepazon cause skin sensitivity or rashes?

Full labeling for this drug class includes warnings about rare but serious skin reactions, such as Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN). The labeling advises that if a rash or blistering occurs, immediate medical attention is sought.

Q: Does Sepazon affect fertility in men or women?

Regulatory documents include data from nonclinical toxicology studies that examine potential impairment of fertility. These findings are used to inform discussions with patients of reproductive potential regarding necessary precautions or concerns.

Q: Is Sepazon available in different strengths?

Official regulatory documents contain a dedicated section that lists all approved Dosage Forms and Strengths in which the product is supplied. This confirms that Sepazon is available in specific, regulated concentrations.

Q: What should I do if I am traveling and need to take Sepazon?

Regulatory agencies (DEA/CBP) provide travel guidelines for controlled substances, which Sepazon is. These guidelines generally recommend that the drug is kept in its original container and that patients are prepared to present documentation when crossing borders.

How should Sepazon be stored and disposed of?

Official Storage and Disposal Instructions

Sepazon (Cloxazolam) must be stored and disposed of according to strict regulatory requirements to maintain its stability and prevent misuse.

Storage & Handling Requirement Official Instruction
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the medicine out of reach of children and away from light, heat, and moisture. Do not freeze.
Packaging Store in the original container to maintain integrity and protection.

Disposal Protocol

Unused or expired medication should be disposed of primarily through a drug take-back program or authorized collection site. If a take-back program is unavailable, follow the household trash method: mix the tablets with an unappealing substance (like used coffee grounds or dirt), seal the mixture in a container, and discard it in the trash. Do not flush the product down the toilet or sink, as it is not on the official FDA flush list.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sepazon found in:

A-Z Index: